Home›People›Janet Foutty
Janet Foutty

Janet Foutty

Director at Quiver Bioscience and senior advisor at WHAM

Director
Updated Nov 9, 2026·Latest SEC filing Oct 21, 2026·Suggest an edit

About Janet Foutty

Janet Foutty is a director of Quiver Bioscience, a company that works on drug discovery. She is also a senior advisor at WHAM, which works to advance investment and innovation in women's health. She is a leadership fellow at the University of Chicago and chair of Bright Pink, a nonprofit for young women's breast and ovarian health.

She worked at Deloitte for 33 years. She also serves as a board member at Argonne National Laboratory and The Chicago Network. She co-wrote the book Arrive and Thrive: 7 Impactful Practices for Women Navigating Leadership.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Janet Foutty in the role, so the role may have started earlier or lasted longer.

Quiver Holdings Inc. Current
Board of Directors
2026 – Present · Cambridge, MA
Quiver Bioscience measures how human neurons function at scale and uses AI to find and test drugs for neurological disease.
WHAM Current
Senior Advisor
Argonne National Laboratory Current
Board member
The Chicago Network Current
Board member
Bright Pink Current
Chair
Deloitte

Key Colleagues at Startups

The people Janet Foutty works with at each company, as listed on that company's latest Form D.

Quiver Holdings Inc. · Form D, Oct 21, 2026
Graham Dempsey
Graham Dempsey
Founder, Chief Executive Officer
David Margulies
David Margulies
Founder, Board Member
Paul Roma
Paul Roma
Founder, Chairman of the Board
Jonathan Fleming
Jonathan Fleming
Board of Directors
Paul Black
Paul Black
Board of Directors

Sources

  1. SECQuiver Holdings Inc. Form D, filed Oct 21, 2026